This medication works by binding to two receptors (GLP-1 and GIP) simultaneously to suppress appetite, support weight loss, and promote metabolic health
Recent Posts Can You Do Laser Hair Removal in the Summer in Lithonia, Lawrenceville & Conyers
Specific Issues Semaglutide : Possibly has a slightly increased rate of gastrointestinal discomfort Tirzepatide : As it is newer, long-term data are still in the process of emerging, but initial studies report a tolerable side effect profile Serious Risks (Rare) Pancreatitis Gallbladder disease Risk of thyroid C-cell tumors (observed in rodent studies) Note: These drugs should not be administered in patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2)
Our compounding labs have advanced technology and follow strict protocols to ensure a clean and controlled environment
Medication costs are separate
Commercial Insurance Trends Mounjaro for diabetes: Generally well-covered by most plans Zepbound for weight loss: Coverage improving but many exclusions remain Both medications: Increasing employer GLP-1 coverage (25%+ expected for 2026) Note: CVS Caremark dropped Zepbound coverage starting mid-2025